TipRanks
Medical Properties Trust (CH:MPT)
:MPT
Switzerland Market

Medical Properties Trust (MPT) Stock Forecast & Price Target

8 Followers
See the Price Targets and Ratings of:

MPT Analyst Ratings

Hold
6Ratings
Hold
2 Buy
1 Hold
3 Sell
Based on 6 analysts giving stock ratings to
Medical
Properties Trust
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

MPT Stock 12 Month Forecast

Average Price Target

CHF4.18
Based on 6 Wall Street analysts offering 12 month price targets for Medical Properties Trust in the last 3 months. The average price target is CHF4.18 with a high forecast of CHF5.84 and a low forecast of CHF3.17. The average price target represents a ― change from the last price of ―.
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
Highest Price TargetCHF5.84Average Price TargetCHF4.18Lowest Price TargetCHF3.17
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan Analyst forecast on CH:MPT
J.P. Morgan
J.P. Morgan
―
Sell
―
Reiterated
09/18/26
Analysts Offer Insights on Real Estate Companies: UDR (NYSE: UDR) and Medical Properties Trust (NYSE: MPT)
KeyBanc
―
Hold
―
Reiterated
09/17/26
KeyBanc Reaffirms Their Hold Rating on Medical Properties Trust (MPT)
Wells Fargo Analyst forecast on CH:MPT
Wells Fargo
Wells Fargo
CHF4.17→CHF3.17
Sell
―
Assigned
09/01/26
Analysts Offer Insights on Real Estate Companies: Douglas Emmett (NYSE: DEI) and Medical Properties Trust (NYSE: MPT)
Bank of America Securities Analyst forecast on CH:MPT
Unknown Analyst
Bank of America Securities
Not Ranked
Bank of America Securities
CHF4.17→CHF3.54
Sell
―
Reiterated
08/17/26
Bank of America Securities Reaffirms Their Sell Rating on Medical Properties Trust (MPT)
Colliers Securities Analyst forecast on CH:MPT
Colliers Securities
Colliers Securities
CHF5.42→CHF4.17
Buy
―
Reiterated
08/12/26
Colliers Securities Sticks to Its Buy Rating for Medical Properties Trust (MPT)
Maxim Group Analyst forecast on CH:MPT
Maxim Group
Maxim Group
CHF6.67→CHF5.84
Buy
―
Reiterated
08/11/26
Analysts Conflicted on These Real Estate Names: Medical Properties Trust (NYSE: MPT) and Essex Property (NYSE: ESS)
RBC Capital Analyst forecast on CH:MPT
RBC Capital
RBC Capital
CHF3.75
Hold
―
Reiterated
06/17/26
RBC Capital Sticks to Their Hold Rating for Medical Properties Trust (MPT)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan Analyst forecast on CH:MPT
J.P. Morgan
J.P. Morgan
―
Sell
―
Reiterated
09/18/26
Analysts Offer Insights on Real Estate Companies: UDR (NYSE: UDR) and Medical Properties Trust (NYSE: MPT)
KeyBanc
―
Hold
―
Reiterated
09/17/26
KeyBanc Reaffirms Their Hold Rating on Medical Properties Trust (MPT)
Wells Fargo Analyst forecast on CH:MPT
Wells Fargo
Wells Fargo
CHF4.17→CHF3.17
Sell
―
Assigned
09/01/26
Analysts Offer Insights on Real Estate Companies: Douglas Emmett (NYSE: DEI) and Medical Properties Trust (NYSE: MPT)
Bank of America Securities Analyst forecast on CH:MPT
Unknown Analyst
Bank of America Securities
Not Ranked
Bank of America Securities
CHF4.17→CHF3.54
Sell
―
Reiterated
08/17/26
Bank of America Securities Reaffirms Their Sell Rating on Medical Properties Trust (MPT)
Colliers Securities Analyst forecast on CH:MPT
Colliers Securities
Colliers Securities
CHF5.42→CHF4.17
Buy
―
Reiterated
08/12/26
Colliers Securities Sticks to Its Buy Rating for Medical Properties Trust (MPT)
Maxim Group Analyst forecast on CH:MPT
Maxim Group
Maxim Group
CHF6.67→CHF5.84
Buy
―
Reiterated
08/11/26
Analysts Conflicted on These Real Estate Names: Medical Properties Trust (NYSE: MPT) and Essex Property (NYSE: ESS)
RBC Capital Analyst forecast on CH:MPT
RBC Capital
RBC Capital
CHF3.75
Hold
―
Reiterated
06/17/26
RBC Capital Sticks to Their Hold Rating for Medical Properties Trust (MPT)
Stocks with the Highest Top Analyst Consensus in the Real Estate Sector
EPRTEssential Properties Realty
IRMIron Mountain
AHRAmerican Healthcare REIT, Inc.
RHPRyman
WELLWelltower
Find stocks in the Real Estate sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Medical Properties Trust

3 Months
Michael MuellerJ.P. Morgan
Success Rate
6/9 ratings generated profit
67%
Average Return
+6.78%
Copying Michael Mueller's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +6.78% per trade.
1 Year
Michael MuellerJ.P. Morgan
Success Rate
5/9 ratings generated profit
56%
Average Return
+2.32%
Copying Michael Mueller's trades and holding each position for 1 Year would result in 55.56% of your transactions generating a profit, with an average return of +2.32% per trade.
2 Years
Michael MuellerJ.P. Morgan
Success Rate
2/9 ratings generated profit
22%
Average Return
-19.42%
Copying Michael Mueller's trades and holding each position for 2 Years would result in 22.22% of your transactions generating a profit, with an average return of -19.42% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MPT Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
1
1
1
1
1
Buy
1
0
1
1
1
Hold
1
1
1
1
1
Sell
0
1
2
4
3
Strong Sell
0
0
0
0
0
total
3
3
5
7
6
In the current month, MPT has received 2 Buy Ratings, 1 Hold Ratings, and 3 Sell Ratings. MPT average Analyst price target in the past 3 months is 4.18.
Each month's total comprises the sum of three months' worth of ratings.

MPT Financial Forecast

MPT Earnings Forecast

Next quarter’s earnings estimate for MPT is >-CHF0.01 with a range of -CHF0.03 to CHF0.03. The previous quarter’s EPS was >-CHF0.01. MPT beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 54.52% of the time in the same period. In the last calendar year MPT has Performed in-line its overall industry.
Next quarter’s earnings estimate for MPT is >-CHF0.01 with a range of -CHF0.03 to CHF0.03. The previous quarter’s EPS was >-CHF0.01. MPT beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 54.52% of the time in the same period. In the last calendar year MPT has Performed in-line its overall industry.

MPT Sales Forecast

Next quarter’s sales forecast for MPT is CHF214.86M with a range of CHF202.97M to CHF222.23M. The previous quarter’s sales results were CHF216.87M. MPT beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 73.09% of the time in the same period. In the last calendar year MPT has Performed in-line its overall industry.
Next quarter’s sales forecast for MPT is CHF214.86M with a range of CHF202.97M to CHF222.23M. The previous quarter’s sales results were CHF216.87M. MPT beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 73.09% of the time in the same period. In the last calendar year MPT has Performed in-line its overall industry.

MPT Stock Forecast FAQ

What is CH:MPT’s average 12-month price target, according to analysts?
Based on analyst ratings, Medical Properties Trust’s 12-month average price target is 4.18.
    What is CH:MPT’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:MPT, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Medical Properties Trust a Buy, Sell or Hold?
        Medical Properties Trust has a consensus rating of Hold, which is based on 2 buy ratings, 1 hold ratings and 3 sell ratings.
          What is Medical Properties Trust’s share price target?
          The average share price target for Medical Properties Trust is 4.18. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is CHF5.84 ,and the lowest forecast is CHF3.17. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Medical Properties Trust?
            Medical Properties Trust’s analyst rating consensus is a Hold. This is based on the ratings of 6 Wall Streets Analysts.
              How can I buy shares of Medical Properties Trust?
              To buy shares of CH:MPT, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.